Nucleic Acid Therapeutics Initiative
  • Organisation
  • Science
  • Accelerator
    • Funding Platform
    • Funding Opportunities
    • Portfolio
  • Careers
  • News & Events

Coacervates Microdroplets for in vivo Delivery of RNA

Posted on August 2, 2025 by Vernacular
← AIFFEL: Generative AI for Full-Length mRNA Therapeutic Design
LNP Platform Technology for Targeted mRNA Delivery →
Email
LinkedIn
Nucleic Acid Therapeutics Initiative (NATi)
31 Biopolis Way, Nanos #09-01, Singapore 138669
© 2026 Nucleic Acid Therapeutics Initiative | Privacy Policy | Terms and Conditions
Nucleic Acid Therapeutics Initiative
Join OurMailing List